95 results
Page 3 of 5
8-K
EX-99.1
hb5i8jj
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
424B5
rxf97ymtcw
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
0bz yiiwrhq
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
kkn9vr ckth9syh2l2
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
xuwpenp4b0 bcwqbvkh
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K
EX-99.2
9rttaledt5hk30a91mx
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
sv53i 6i1
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
hvw1mhbf 2r
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
bp5516m a1
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
kf449v7yq zuy0
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
EX-99.1
db1pzm
6 Nov 19
Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples
4:08pm
8-K
EX-99.1
bltjh9 uy5z3cl0re33
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm